← USPTO Patent Applications

COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED GENE TARGETING FOR THE TREATMENT OF GENETIC DISORDERS IN ADULT PATIENTS

Application US20260077061A1 Kind: A1 Mar 19, 2026

Assignee

The Trustees of the University of Pennsylvania

Inventors

James M. Wilson, Lili Wang

Abstract

A dual component system for treating a genetic disorder is provided. The system includes (a) a gene editing vector comprising an expression cassette comprising a nucleic acid sequence encoding a nuclease and regulatory sequences that direct expression of the nuclease in a target cell comprising a PCSK9 gene; and (b) a donor vector comprising a nucleic acid sequence encoding an exogenous product for expression from the PCSK9 locus, wherein the inserted nucleic acid sequence does not encode PCSK9, wherein the system further comprises sequences that direct the nuclease to specifically targets the native PCSK9 gene locus; and wherein the native PCSK9 in the target cell is optionally ablated or reduced post-dosing with the dual component system.

CPC Classifications

A61K 48/0058 A61K 38/4846 A61K 48/0075 A61K 48/0083 A61P 7/04 C07K 14/005 C12N 9/226 C12N 15/111 C12N 15/86 C12N 15/88 C12N 15/907 C12Y 304/21022 C12Y 304/21061 C12N 2310/20 C12N 2750/14122 C12N 2750/14143

Filing Date

2023-07-14

Application No.

18994165